Voloridge Investment Management, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $12.5 Million - $16.7 Million	54,232 Added 1094.05%	59,189 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $289,439 - $1.47 Million	4,957 New	4,957 $1.44 Million
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $2.01 Million - $2.51 Million	-20,174 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $1.21 Million - $2.54 Million	20,174 New	20,174 $2.29 Million
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $1.72 Million - $2.4 Million	-16,664 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $1.58 Million - $3.59 Million	16,664 New	16,664 $1.88 Million

296

21.9M

819K

644K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.52B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.